Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postleukemic dysmyelopoiesis.

K Foucar, W P Vaughan, J O Armitage

    American Journal of Hematology
    |December 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editor's Choice - Management of Descending Thoracic Aorta Diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2017
    Same author

    A Great Era Comes to an End: And a New One Begins!

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016
    Same author

    Significance and Limitations of the p Value.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015
    Same author

    MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.

    Cell death and differentiation·2015
    Same author

    Protective effect of focal adhesion kinase against skeletal muscle reperfusion injury after acute limb ischemia.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015
    Same author

    Commentary on "biochemical and immunomorphological evaluation of hepatocyte growth factor and c-Met pathway in patients with critical limb ischemia": regenerative therapy of chronically ischaemic wounds: land in sight?

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014
    Same journal

    Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.

    American journal of hematology·2026
    Same journal

    Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial.

    American journal of hematology·2026
    Same journal

    Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

    American journal of hematology·2026
    Same journal

    Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B-ALL.

    American journal of hematology·2026
    Same journal

    Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.

    American journal of hematology·2026
    Same journal

    Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

    American journal of hematology·2026
    See all related articles

    Four patients developed significant bone marrow and blood dyspoiesis after acute nonlymphocytic leukemia (ANLL) chemotherapy. This prolonged condition, resembling preleukemic disorders, occurred without relapse signs and may indicate drug-induced leukemia cell differentiation.

    Area of Science:

    • Hematology
    • Oncology
    • Medical Science

    Background:

    • Acute nonlymphocytic leukemia (ANLL) treatment often involves intensive chemotherapy.
    • Understanding long-term treatment sequelae is crucial for patient management.
    • Post-treatment bone marrow abnormalities require further investigation.

    Observation:

    • Four ANLL patients exhibited significant bone marrow and blood dyspoiesis 1-6 months post-chemotherapy.
    • These dyspoietic changes persisted for 5-20 months without signs of leukemia relapse.
    • Abnormalities were more pronounced than in control ANLL patients on maintenance therapy.

    Findings:

    • Morphologic features of postleukemic dysmyelopoiesis resembled preleukemic disorders.
    • Erythroid abnormalities included ring sideroblasts and megaloblastic changes.

    Related Experiment Videos

  • Myeloid abnormalities showed left-shifted granulopoiesis and megakaryocytic hyperplasia with hypolobulated forms.

    • Implications:

    • Postleukemic dysmyelopoiesis may represent drug-induced leukemia cell differentiation.
    • Cytogenetic studies are needed to confirm the relationship between ANLL and subsequent dysmyelopoiesis.
    • This phenomenon highlights potential long-term complications of ANLL treatment.